A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

EMBO Molecular Medicine, EarlyView.

Source: EMBO Molecular Medicine - October 30, 2018 Category: Molecular Biology Authors: Marta Castroviejo ‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, Mandy Ducy, Yasir Hussein Ibrahim, Albert Gris‐Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Source Type: research